Italia markets closed

BMY Aug 2025 52.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,50000,0000 (0,00%)
In data: 02:13PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente2,5000
Aperto2,5000
Denaro1,3600
Lettera2,5900
Prezzo d'esercizio52,50
Scadenza2025-08-15
Min-Max giorno2,5000 - 2,5000
Contratto - Min-MaxN/D
Volume7
Open Interest80
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri